Cite
APA Citation
Rucinska, M., Osowiecka, K., & Nawrocki, S. (n.d.). sHARP hypofractionated stereotactic radiotherapy is low and intermediate-risk prostate carcinoma patients – PSA outcome. European journal of cancer, 72, S193–S194. http://access.bl.uk/ark:/81055/vdc_100041522304.0x000047